Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,829
Closed -$819K 1017
2026
Q1
$819K Buy
10,829
+2,273
+27% +$171K 0.01% 695
2025
Q4
$637K Hold
8,556
﹤0.01% 609
2025
Q3
$577K Sell
8,556
-76,200
-90% -$5.06M ﹤0.01% 701
2025
Q2
$5.52M Hold
84,756
0.04% 158
2025
Q1
$5.24M Sell
84,756
-1,422
-2% -$94.2K 0.05% 152
2024
Q4
$6.21M Sell
86,178
-54,036
-39% -$4.22M 0.05% 144
2024
Q3
$11.4M Sell
140,214
-20,600
-13% -$1.65M 0.11% 93
2024
Q2
$11.9M Buy
160,814
+2,314
+1% +$173K 0.12% 84
2024
Q1
$12.4M Hold
158,500
0.14% 62
2023
Q4
$11.3M Buy
+158,500
New +$11M 0.14% 64
2017
Q3
Sell
-50,200
Closed -$2.28M 468
2017
Q2
$2.28M Buy
+50,200
New +$2.22M 0.03% 151

Other funds holding HOLX

OMERS Administration Corp's HOLX Position: Q2 2026 in Review

OMERS Administration Corp sold out of Hologic (HOLX) in Q2 2026, closing a stake of 10,829 shares — an estimated $819K sold.

OMERS Administration Corp first reported a position in HOLX in Q2 2017 and held it in 11 quarters. The position peaked at $12.4M in Q1 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • OMERS Administration Corp reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 10,829 Hologic shares in Q2 2026, an estimated $819K.
  • OMERS Administration Corp first reported a position in Hologic in Q2 2017 and held it in 11 quarters.
  • OMERS Administration Corp's Hologic position peaked at $12.4M in Q1 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.